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Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is a known outcome of hepatosteatosis. Free fatty acids (FFA) induce
the unfolded protein response (UPR) or endoplasmic reticulum (ER) stress that may induce apoptosis. Recent data indicate
ER stress to be a major player in the progression of fatty liver to more aggressive lesions. Autophagy on the other hand has
been demonstrated to be protective against ER stress- induced cell death. We hypothesized that exendin-4 (GLP-1 analog)
treatment of fat loaded hepatocytes can reduce steatosis by autophagy which leads to reduced ER stress-related hepatocyte
apoptosis.
Methodology/Principal Findings: Primary human hepatocytes were loaded with saturated, cis- and trans-unsaturated fatty
acids (palmitic, oleic and elaidic acid respectively). Steatosis, induced with all three fatty acids, was significantly resolved
after exendin-4 treatment. Exendin-4 sustained levels of GRP78 expression in fat-loaded cells when compared to untreated
fat-loaded cells alone. In contrast, CHOP (C/EBP homologous protein); the penultimate protein that leads to ER stress-related
cell death was significantly decreased by exendin-4 in hepatocytes loaded with fatty acids. Finally, exendin-4 in fat loaded
hepatocytes clearly promoted gene products associated with macroautophagy as measured by enhanced production of
both Beclin-1 and LC3B-II, markers for autophagy; and visualized by transmission electron microscopy (TEM). Similar
observations were made in mouse liver lysates after mice were fed with high fat high fructose diet and treated with a long
acting GLP-1 receptor agonist, liraglutide.
Conclusions/Significance: GLP-1 proteins appear to protect hepatocytes from fatty acid-related death by prohibition of a
dysfunctional ER stress response; and reduce fatty acid accumulation, by activation of both macro-and chaperone-mediated
autophagy. These findings provide a novel role for GLP-1 proteins in halting the progression of more aggressive lesions
from underlying steatosis in humans afflicted with NAFLD.
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Introduction
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of
chronic diseases including fatty liver, or bland steatosis, as well as
more aggressive lesions including steatohepatitis, lobular necroin-
flammation with fibrosis, or cirrhosis. NAFLD-related cirrhosis
can lead to end-stage liver disease and hepatocellular carcinoma
(HCC). Like other chronic end-stage liver diseases the major
option for afflicted persons is liver transplantation. NAFLD
appears to be associated with obesity and insulin resistance, and
is considered the hepatic manifestation of the metabolic syndrome,
along with type 2 diabetes mellitus (T2DM) and certain
dyslipidemias [1]. An important component of Western diets
includes both saturated fatty acids as well as trans-saturated fatty
acids. Recent evidence indicates that such fatty acids are partly,
responsible for inducing steatosis and fueling hepatocyte insulin
resistance [2].
GLP-1 is an incretin that is released from the L-cells of the small
intestine which targets pancreatic ß-cells to release insulin and
reduce glucagon production in response to food intake [3]. Insulin
resistance also results in defective glucagon like peptide-1 (GLP-1)
release [4]. Recently we demonstrated that GLP-1 receptors
are present on human hepatocytes [5] and that exposure of
hepatocytes to GLP-1 receptor agonists led to a reduction of fat
load in hepatocyte cell lines, HepG2 and Huh7. Little work,
however, has been performed in primary human hepatocytes in
vitro to elucidate the lethal potential of such fatty acids discussed
previously [6].
Fatty acids are known to induce the unfolded protein response
(UPR), a compensatory cellular mechanism to handle cell stress
[7]. This process, including protein degradation and inhibition of
translation allows cells to survive stress caused by defective
proteins. In addition to the UPR an additional component to
maintain a healthy proteome in the cell - lysosomal degradation or
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toxic fatty acids from cells. In addition to defective protein
degradation, lysosomes have also been shown to degrade other
intracellular components, including whole organelles, lipid depos-
its, proteinaceous inclusions and aggregates [8,9]. Singh et al.
(2009) recently demonstrated that a fatty acid load in mouse
hepatocytes is reduced by macroautophagy [10]. Another type of
autophagy, chaperone mediated autophagy (CMA) has also been
demonstrated to reduce cell stress by removing proteins that have
a signal sequence [11]. While the molecular details regarding
chaperone mediated autophagy (CMA) are less well-developed
regulators of CMA have recently been identified in murine
hepatocytes [12].
Investigations exploring the role of GLP-1 in fatty acid-induced
pancreatic beta cell UPR have demonstrated that excitation of
GLP-1 receptor in ß-cells leads to improvement in cell survivability
[13,14,15]; however it is not known whether GLP-1 reduced the
fatty acid burden by regulating either macroautophagy or
lipoautophagy; or whether chaperone mediated autophagy plays
a beneficial role. With this background we investigated the ability
of human hepatocytes (in vitro) and murine hepatocytes, in an in vivo
animal model of high fat high fructose feeding, to handle
hepatocyte steatosis in response to GLP-1 analogs.
Results
Primary Human Hepatocytes
Exendin-4 reduces steatosis and enhances survivability in
hepatocytes. Very limited published studies have investigated
models of steatosis in primary human hepatocytes. We employed
primary human hepatocytes to confirm their potential as in vitro
model to study hepatocyte steatosis. Fat loading was observed by
staining the lipid droplets with Oil red O. Microscopic
observations of free fatty acids (FFA) treated primary human
hepatocytes revealed that conspicuous steatosis (Fig. 1A) were
caused by the cis-, trans-unsaturated, and saturated fatty acids
(oleic, elaidic and palmitic respectively). We treated human
hepatocytes engorged with FFA with exendin-4 to first
determine if it led to reduction in FFA stores; and, whether
exendin-4 protected such hepatocytes from apoptosis. We
observed that steatosis was significantly reduced after exendin-4
treatment (Fig.1A). Quantification of Oil red O stain corroborated
these findings and demonstrated a fifty percent reduction in fat
load regardless of the FFA used for fat-loading (Fig. 1B).
Hepatocytes treated with fatty acids alone demonstrated
reduced survival as measured by cleavage of tetrazolium salt
XTT to correlate hepatocyte viability. Cells that were treated with
exendin-4 showed a higher dye concentration in comparison to
cells with FFA alone (Fig. 2A). This suggested that exendin-4
resulted not only in reduction of FFA stores in the cells, but also
improved mitochondrial function and survival. On examination of
fat loaded and exendin treated cells with DAPI, we found a
reduction in DNA condensation in comparison to only fat loaded
cells (Fig. 2B). Quantification of the percent cells with DNA
condensation (Fig. 2C) confirmed our observations. To confirm if
this improvement was a result of reduced apoptosis we examined
cleaved caspase 3 levels in cells treated with exendin-4. Immu-
noblots revealed that there was a marked decrease in cleaved
caspase 3 in exendin treated cells (Fig. 2D), supporting our
survivability assay.
Fatty acid induced ER stress is mitigated by GLP-1
analogs. It is well known that FFA causes ER stress [7,16],
which if uncontrolled can lead to cell death by apoptosis.
Apoptotic cell death is believed to be the principle mechanism
whereby NAFLD can progress to more significant lesions
including non-alcoholic steatohepatitis (NASH) and NASH-
related hepatic fibrosis [17]. Phosphorylation of PERK and
splicing of XBP were used as markers to confirm setting in of ER
stress (Fig. S1- A, C). PERK phosphorylation was higher in fat
treated cells but did not show difference after exendin-4 treatment
from the fat loaded cells (Fig. S1- A, B). XBP splicing indicated ER
stress establishment in fat-only treatments, which was suppressed
after exendin-4 (Fig. S1- C: OA, PA, and EA). From the data we
concluded that hepatocytes were under ER stress after fat
treatments. We speculated that cell death observed in primary
hepatocytes may be a consequence of the inability of the ER stress
mechanism to handle excess unfolded proteins resulting from
excess stress due to FFA-hepatocyte loading. To verify our
concerns, we measured the expression of glucose regulated
protein, GRP78, the key chaperone protein that mediates the
ER stress response to prevent its dysfunction and ultimately
prevents cell death. Immunoblots demonstrated that exendin-4
treatment of elaidic acid-loaded hepatocytes (EAE) led to a
significant increase in GRP78 levels in contrast to levels
determined in elaidic acid loaded hepatocytes (EA) alone (Fig.
3A, B). Exendin-4 significantly increased GRP78 mRNA
expression in all FFA-loaded cells when compared to FFA-
loaded hepatocytes alone (Fig. 3D). Interestingly, oleic and
palmitic acid led to an increase of GRP78 at the message level
but not at the protein level, which was lower than the control.
C/EBP homologous protein (CHOP) has been identified as a
crucial link between a dysfunctional ER stress and apoptosis and is
a highly expressed gene during ER stress [18]. Corresponding to
the increased ER stress caused by FFAs, CHOP protein levels
were increased. In contrast, exendin-4 reduced CHOP expression
both at the protein and mRNA levels regardless of the FFA type
loaded (Fig. 3A, C, and E). It is noteworthy that while all the fatty
acids induced the expression of CHOP, exendin-4 treatment
suppressed the levels three fold in both oleic and palmitic acid
loaded hepatocytes in comparison to elaidic acid. We did not find
significant difference in 18s rRNA expression levels between
treatments (Fig. S2).
GLP-1 reduces fat load in hepatocytes by inducing
autophagy. Recently, macroautophagy has been identified as
a mechanism for removal of fatty acid loads from hepatocytes. We
wanted to confirm if GLP-1 analogs induced autophagy in fat
loaded cells. Examination of autophagy related genes and proteins
revealed that GLP-1 analog treatments both in vitro and in vivo
increased key proteins associated with macroautophagy. Beclin
and LC3B-II are two key proteins associated with macro-
autophagy. Exendin-4 significantly increased beclin protein levels
except in oleic acid-treated hepatocytes where the change was
insignificant; and exendin-4 also significantly increased the
conversion of LC3-B1 to LC3B-II (Fig. 4A, B).
These observations were in agreement with mRNA expression
levels also. Beclin expression levels were decreased in response to
saturated fatty acid in contrast to unsaturated cis- or trans-fatty
acids (Figure 4C). Exendin-4 was unable to enhance these levels in
cells treated with oleic acid. Providing exendin-4 after both elaidic
and palmitic acids enhanced Beclin expression. LC3B gene
expression also showed a similar trend except for oleic acid
treatment. Here the expression levels were significantly suppressed
by exendin treatment, although they still remained significantly
higher than control (Fig. 4C).
Another type of autophagy, chaperone mediated autophagy
(CMA) has also been implicated in clearing toxic stress from cells.
CMA is known to target proteins that carry a signal peptide and
can occur in the absence of autophagosomes but presence of
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been identified as a marker for this mechanism. We investigated
the profile of LAMP2A in exendin-4 treated and control fat-loaded
hepatocytes. While there was a marked increase in the protein
levels of LAMP2A in cells treated with plamitic acid followed by
exendin-4 treatment, levels were relatively lower in hepatocytes
treated with elaidic acid (Fig. 4A, B). Oleic acid and exendin-4
treatment on the other hand did not reveal a difference in the
resulting amount of LAMP2A. LAMP2A gene expression on the
other hand showed an increase in elaidic- and palmitic acid
treatments, while it was suppressed in oleic acid after exendin-4
treatment (Fig. 4C). Additionally, to confirm if exendin was
actually affecting the autophagic flux, cells were treated with
bafilomycin (a vacuolar-type H+-ATPase inhibitor). Since bafilo-
mycin inhibits the fusion of autophagosomes to lysosomes, we
estimated the accumulation of autophagosomes by measuring
LC3-II under bafilomycin treated and untreated conditions
between cells treated with palmitic acid and/or exendin-4. Under
bafilomycin treated conditions there was an increase in LC3-II
labeling in contrast to non-bafilomycin conditions (Fig 5A (i)). To
estimate autophagic flux, the ratio of densitometry values of LC3-
II bands from control, palmitic acid, exendin and palmitic acid +
exendin in presence of bafilomycin to their respective bafilomycin-
free samples was taken. The result (Fig. 5A (ii)) shows that while
Figure 1. Exendin-4 treatment reduces fatty acid load in hepatocytes. Primary human hepatocytes were treated with fatty acids for 24 h and
then supplemented with exendin-4 in fresh media. Hepatocytes treated with fatty acids were cultured for additional 24 h. (A) Primary human
hepatocytes treated with exendin-4 (+) demonstrate reduction of fat load as quantified by Oil Red O staining of intracellular lipid droplets (B). (C:
control; Ex: exendin-4; OA: oleic acid; OAE: oleic acid with exendin-4; PA: palmitic acid; PAE: palmitic acid with exendin-4; EA: elaidic acid; EAE: elaidic
acid with exendin-4). Three independent experiments with three replicates each were conducted *p,0.001, Tukey-Kramer.
doi:10.1371/journal.pone.0025269.g001
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flux even in the presence of palmitic acid. It should be noted that
while exendin appears to be lowering the autophagic flux in
comparison to control, the difference is not statistically significant.
To confirm if the increase in autophagy related genes actually
resulted in an increased number of autophagosomes and whether
there was indeed more lipophagy, we examined samples by
transmission electron microscopy (TEM). Total number of
autophagosomes that had lipid droplets in them and the total
number of autophagolysosomes (AL) with lipid droplets were
measured. Together these bodies are taken as autophagic vacuoles
(AV) [Fig. 5B (i–iv)]. Exendin treatment increased the number of
AVs, although the number of autophagosomes and ALs varied
with treatment. In oleic acid treated hepatocytes there was an
insignificant change in AVs after exendin treatment, although the
autophagosome count was significantly increased by exendin-4.
There was a clear increase in both autophagosomes and ALs
under palmitic acid and exendin treatments (Fig. 5C). Elaidic acid
treatment with or without exendin resulted in a similar number of
autophagosomes, however, exedin-4 treatment significantly in-
creased the number of ALs (Fig. 5C).
While visualizing cells for AVs we observed that some large
sized lipid droplets had ‘shriveled’ margins with distinct absence of
autophagic vacuoles around them [Fig. 5 (v)]. We hypothesized
that this may be a result of change in contents of the lipid droplet,
perhaps due to transport of fatty acids for beta oxidation. To
confirm enhanced b-oxidation we determined the concentration of
ketone bodies, the final breakdown product of beta oxidation. ß
hydroxybutyrate served as a marker for oxidation. Exendin-4
treatment increased the production of ketone bodies in all the
treatments in comparison to control. Fatty acids themselves also
led to an increase in ketone bodies probably as a normal cellular
response, which was further enhanced by exendin-4. The
difference between exendin treated and untreated fat loaded cells
Figure 2. Exendin-4 suppresses apoptosis in primary human hepatocytes. (A) Hepatocyte survival increased after exendin-4 treatment as
measured by XTT assay. (B) DNA condensation as observed by DAPI staining of cells treated with different fatty acids and exendin-4. Damaged DNA is
marked by white arrows (C). (D) Exendin-4 treatment led to suppression of apoptosis as demonstrated by reduction in cleaved caspase 3. These
experiments were performed three times in triplicate, #p,0.001, *p,0.05, Tukey-Kramer.
doi:10.1371/journal.pone.0025269.g002
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treatment increased significantly ketone body formation in cells
loaded with either palmitic or elaidic acid exposure (Fig. S3).
American Lifestyle-Induced Obesity Syndrome (ALIOS)
Model
Oil red O staining of liver sections from animals fed normal
chow, ALIOS diet and subsequently treated with liraglutide
illustrated a marked reduction in the lipid load in hepatocytes.
Also, there was a clear reduction in hepatic steatosis in drug
treated animals (Fig. 6A). We further investigated the liver lysates
for markers of UPR by immunoblotting and immunohistochem-
istry. Immunoblotting revealed suppression of GRP78 levels in
animals fed ALIOS diet. Liraglutide injections in animals fed
ALIOS diet reversed this effect by increasing GRP78 (Fig. 6B).
Livers from animals administered the ALIOS diet demonstrated
Figure 3. GLP-1 analogs reduce ER stress in hepatocytes. (A). Immunoblot of ER stress marker proteins GRP78 and CHOP. (B) GRP78 protein
levels were increased in following primary hepatocyte cultures in presence of exendin-4 for 24 h. GRP78 levels were significantly increased by oleic
acid more than by either palmitic or elaidic acid. (C) CHOP expression was significantly reduced by exendin-4, with maximum reduction from lysates
obtained from elaidic acid-loaded hepatocytes. (D–E) Percent change over control in the expression levels of GRP78 and CHOP in human hepatocytes
as calculated by RT-qPCR analysis. Representative blots from different independent experiments are presented here. #p,0.001, *p,0.05, Tukey-
Kramer.
doi:10.1371/journal.pone.0025269.g003
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given normal chow. In contrast, liraglutide treated mice had a
remarkable reduction in CHOP protein levels (Fig. 7B). Densito-
metric analysis of the immunoblots confirmed these observations
(Fig. 6C). In order to confirm if this difference in protein quantities
was due to a transcriptional or post-transcriptional event, RT-
qPCR analysis was carried out for these two genes. Results
revealed that liraglutide treatment enhanced GRP78 and
suppressed CHOP expression (Fig. 6D). We extended these
studies by visualizing GRP78 and CHOP protein levels in liver
sections by immunohistochemistry. Differences in the amount of
signal for GRP78 and CHOP were similar to those observed by
immunoblotting (Fig. 7A).
Investigations by Liu et al. (2009) have demonstrated that high
fat diet leading to hyperinsulinemia and insulin resistance
suppresses autophagy. In order confirm this in animals fed the
ALIOS diet, we investigated autophagy markers beclin1, LC3B
conversion, and LAMP2 in mouse livers. As is evident from Fig.
Figure 4. GLP-1 analogs induce macroautophagy and lysosomal turnover. (A) Immunoblot of human hepatocytes for autophagy related
proteins – beclin-1, LC3B and LAMP2A. Note the increased conversion of LC3B-I to LC3B-II in samples treated with exendin-4. (B) Densitometric
analysis of immunoblots. For LC3B 16 kDa band was quantified. (C) Beclin, LC3B and LAMP2A gene expression levels were elevated in exendin-4
treated cells, as quantified by RT-qPCR. In (B) and (C) significance was determined by comparing exendin-4 treated samples vs. its respective fat
loaded sample for each gene. These experiments were repeated three times in triplicate, #p,0.001, *p,0.05, Students t test.
doi:10.1371/journal.pone.0025269.g004
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ALIOS diet. Liraglutide injections in these animals increased
beclin1 protein levels in liver. Similarly, LC3B-I was higher in
animals fed high fat diet, whereas, LC3B-I was converted to
LC3B-II in animals additionally injected with liraglutide. Exam-
ination of the lysosomal marker LAMP2 also considered a
Figure 5. Exendin-4 stimulates autophagic vacuoles formation in human hepatocytes. (A) (i) Immunoblot for LC3 in palmitic acid and/or
exendin-4 treated samples in presence or absence of bafilomycin A1. (B: bafilomycin A1; BPA: bafilomycin with palmitic acid; BEx: bafilomycin with
exendin-4; PABEx: palmitic acid with bafilomycin and exendin-4). (ii) Autophagic flux depicted as values obtained after taking the ratio of
densitometry values of LC3-II values from bafilomycin treated samples to their respective bafilomycin-free counterparts. Note the increase in
autophagic flux in response to exendin-4 in the presence of palmitic acid against palmitic acid alone. (B) Electron microscopy of primary human
hepatocytes (i) showing fat loading, (N: nucleus; LD: lipid droplet), (ii) structure of lipid droplets, (iii) autophagosomes containing lipid droplets (red
arrow), (iv) autophagolysosome with lipid autophagosome and lipid droplet (iv) and, (v) shriveled lipid droplet (red arrow). Magnification: (i) – (ii)
x3.5E10
2, (iii) – (v) x25E10
3.( C) Quantification of autophagic vacuoles (autophagosomes containing lipid droplets – dark bands, and auto-
phagolysosomes containing lipid droplets – light bands) by integer scoring. #p,0.001, *p,0.05, Student’s t-test, three independent experiments
were performed.
doi:10.1371/journal.pone.0025269.g005
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es between high fat diet fed and GLP-1 analog treated mice.
Densitometry of these immunoblots substantiated these findings
(Fig. 7C). RT-qPCR analysis of beclin1 and LC3B disclosed that
the increase in protein levels was an outcome of four-fold and
three-fold increase in expression levels of beclin1 and LC3B genes,
respectively (Fig. 7D). Taken together these findings confirm that
while a Western diet (ALIOS) can suppress autophagy, GLP-1
analog treatment can reverse autophagic inhibition in mouse liver.
Discussion
NAFLD refers to the spectrum of liver diseases in which
steatosis can, in some humans, progress to more significant
pathology including NASH and NASH-related cirrhosis. The
accumulation of fat in hepatocytes is a consequence of three
principle sources: de novo lipogenesis in the liver; nutritional uptake
from the small intestine; and free fatty acid release from visceral
white adipose tissue [19]. In one way or another each of these fatty
Figure 6. Liraglutide treatment reduces steatosis and ER stress in high fat diet fed mice. Mice were fed American Lifestyle-Induced
Obesity Syndrome (ALIOS) diet and high fructose corn syrup for 8 weeks. One set of animals was subsequently treated with 200 mg/kg body weight
liraglutide for next 4 weeks while maintaining other on high fat high sucrose diet. (A). Oil Red O staining of liver sections from mice kept on normal
chow and treated with saline [C], liraglutide [L] and those given ALIOS diet alone [A] and subsequently liraglutide [AL]. (B) Immunoblotting of mouse
liver lysates for GRP78 and CHOP. (C) Densitometric analysis of immunoblot (C: control, L: liraglutide treated, A: ALIOS fed, A+L: ALIOS fed and then
liraglutide injected). (D) Real time mRNA quantification of GRP78 and CHOP. (E) Immunohistochemical staining of mouse liver sections for GRP78 and
CHOP. All studies were conducted at least three times in triplicate with fresh lysates, *p,0.05 Student’s t-test.
doi:10.1371/journal.pone.0025269.g006
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fructose corn syrup) or fatty acids that are highly saturated or have
an all trans- structure. This diet results in both peripheral and
hepatic insulin resistance. Recent data, however, indicate that the
production of triglycerides may be a safety valve for hepatocytes
prone to danger from lipotoxicity, the term used to describe the
potential harm of long chain, saturated fatty acids. In this study we
investigated whether the GLP-1 analogues could augment
protective mechanisms in human hepatocytes that accumulated
specific fatty acids; or in a mouse-feeding model with a diet as
described above and consumed by Westerners.
Fatty acids available from the high fat diet are known to induce
ER stress in hepatocytes [1]. Persistent ER stress results in rapid
accumulation of unfolded proteins, which triggers apoptosis
[20,21,22]. Gores recently demonstrated that free fatty acids
loaded in mouse hepaotcytes directly engaged the apoptotic
machinery by activating Bax, in a c-jun N-terminal kinase-
dependent manner [1]. Both our in vitro and in vivo results here
concur with their observations. As evident from Figure 2A,
different fatty acids impart differential viability to hepatocytes,
suggesting that all fatty acids are not equally toxic. On the other
hand, earlier work on GLP-1 analogs has demonstrated protection
of pancreatic ß-cells from ER stress and apoptosis [15,23]. Since
we recently identified the presence of GLP-1 receptors on the
human hepatocyte [5], we set out to investigate potential
mechanisms whereby GLP-1 reduces the free fatty acid burden
in human cells. In vitro experiments presented here revealed that
saturated, cis- and trans-unsaturated fatty acids have a variable
effect on hepatocyte survival. Cell viability was reduced following
fat loading and correlatively cell death was an outcome of
apoptosis, as observed by an increase in cleaved caspase 3 and
DAPI imaging. We also observed a marked reduction in cleaved
caspase 3 following treatment with exendin-4 in cells containing
fat when compared to non-fat loaded hepatocytes. We speculated
that cell survival was the consequence of enhanced capacity to
handle the unfolded protein response (UPR) and thereby prevent
hepatocyte cell death via apoptosis.
GRP78 is the cardinal chaperone protein that binds to
unfolded proteins and reduces ER stress, preventing ATF-6
activation that in turn promotes CHOP expression and initiates
downstream apoptosis effectors [24]. We observed that exendin-4
induced the expression of GRP78 in hepatocytes and liraglutide
did the same in mouse livers fed a high fat high fructose diet.
These data suggest that while free fatty acids result in an increase
in unfolded protein accumulation, there is an insufficient or
effective level of GRP78 to abate the unfolded protein response.
Exendin-4 on the other hand increased the amount of GRP78.
Furthermore, if ER stress persists; C/EBP homologous protein
(CHOP) activation can promote an imbalance between survival
and apoptosis in favor of the latter. CHOP is ubiquitously
expressed at very low levels. However, it is robustly expressed by
perturbations that induce stress [25]. As we observed in vitro,F F A
induced stress leads to an accumulation of CHOP. This
observation is in contrast to that of Puri et al. [17], where
CHOP expression was suppressed in NAFL and NASH in human
liver samples. We demonstrated here that CHOP levels were
increased in hepatocytes that showed high steatosis with either of
the fatty acid types. This expression is reversed following exendin-
4 treatment. These data were also seen following liraglutide
therapy in the ALIOS-fed mice. Taken together, increased
availability of the chaperone GRP78 and reduction in CHOP
expression provides stress-relief to hepatocytes, suppressing
apoptosis and promoting hepatocyte survival.
We are currently investigating the specificity of this effect of
GLP-1 via upstream mechanisms related to the G-protein coupled
receptor (GPCR). GLP-1R since it has been shown previously that
GLP-1 may act through cAMP and exhibit its protective effects
through the activation of protein kinase B/Akt through a cAMP-
dependent phosphorylation of cAMP-responsive element-binding
protein (CREBP) [26,27,28]. Immunohistochemical staining of
liver sections for GRP78 and CHOP in mice given ALIOS diet
and liraglutide suggest that GLP-1 analogs impart a strong affect
in liver; though reduction in hepatic steatosis could as well be a
result of whole body response to liraglutide, since GLP-1 receptors
are present in other organs also. Recently there has been a surge of
studies on the role of autophagy in maintaining cell signaling and
health particularly in relation to diseases [29,30]. Li et al. [31]
have demonstrated that in mammalian cells knockdown of GRP78
leads to a reduction in autophagosome formation, though the
conversion of LC3-I to LC3-II was not affected. Autophagy has
also been implicated in cell death via apoptosis. Depending upon
the kind and severity of stress it is possible that autophagy may
determine cell fate [32,33]. Most of the studies investigating
autophagy have used starvation as a source of its induction.
Physiologically autophagy occurs not only in response to starvation
but also as a homeostatic process, conserved in all eukaryotes,
whereby cellular contents can be delivered to the lysosome to yield
recyclable nutrient components and rid cells of potentially
deleterious proteins, organelles and pathogens [29]. Only recently
studies by Singh et al. [10] have demonstrated autophagy to be
targeting lipids inside the cell — and the concept of lipoautophagy
emerged. Although we had no prior information suggesting that
GLP-1 proteins promote autophagy, the disappearance of fatty
Figure 7. ALIOS-fed mice treated with liraglutide confirm GLP-
1 enhanced lipoautophagy in liver. (A). Immunoblot comparing
beclin, LC3B conversion and LAMP2 levels in liver lysates from mice
treated with liraglutide or ALIOS diet or combination thereof. (B)
Quantification of immunoblot by densitometry. Differences between
protein levels were significant for respective genes between ALIOS and
ALIOS+Liraglutide samples (C) Real time PCR analysis of Beclin, LC3B
and LAMP2 gene expression. Histogram shows fold change in ALIOS-
fed, liraglutide treated animals versus ALIOS fed animals. These
experiments were performed with lysates from six mice, *p,0.05
Student’s t-test.
doi:10.1371/journal.pone.0025269.g007
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examine this process.
Exendin-4 increased the rate of autophagosome and autopha-
golysosome formation or the autophagic flux. Furthermore,
exendin-4 induced key protein makers of autophagy both at the
mRNA and protein levels. These data were identical in both the in
vitro and in vivo models employed here. Beclin and LC3B were
increased in mice treated with liraglutide. High fat diet suppressed
the expression of these genes and consequently their proteins.
These observations are consistent with those made by Liu et al.
[34] where they demonstrated that autophagy is suppressed when
mice are fed a high fat diet. Additionally, we observed an increase
in LAMP2A. This protein is associated with the lysosomal
membrane and is a key component of chaperone mediated
autophagy (CMA). While we did not investigate CMA mecha-
nisms it is possible that CMA is also activated in response to
exendin-4 along with macroautophagy. LAMP2A has been shown
to be an important component of lysosomes involved in fusion of
the autophagosomes to lysosomes [35]. Investigations by Koga et
al. [36] have revealed that mice fed a high fat diet had an
autophagosome/lysosome fusion disorder. In our studies the high
fat diet also suppressed markers of autophagy. These markers,
however, were substantially increased transcriptionally in GLP-1
analog treated mice. The mechanism by which GLP-1 analogs
induce such an effect needs further investigation. We, therefore,
assume that an increase in macroautophagy guides the cell to
increase in the number of lysosomes to accommodate increased
flux of autophagosomes.
In addition to the increased number of autophagic vacuoles,
larger lipid droplets showed ‘shriveled’ edges in absence of any
autophagic vacuole. This prompted us to launch an investigation if
there markers of enhanced ß-oxidation in response to exendin-4
could be detected. We examined culture media for the release
keto-bodies (ß-hydroxybutyrate) and found an increase in these
bodies in samples treated with exendin-4 (Fig. S3). Studies have
reported that GLP-1 does not lead to an increase in ß-oxidation in
mice pancreatic cells [37,38]. Our data alone cannot implicate
that GLP-1 directly increases ß-oxidation. It is tempting to
speculate, however, that oxidation may be a result of decreased
stress and fat load via autophagy, which is enhanced at the
transcriptional level by exendin-4 and is further maintained by an
increase in GRP78; hence additional experiments will be required
to gain insight into the exact mechanisms of autophagic regulation
by GLP-1 analogs. Down-regulation of the insulin receptor (IR)
protein levels in insulin-target tissues such as liver, skeletal muscle,
and adipose tissue has been shown to correlate with insulin
resistance [39,40,41]. Zhou et al. [42] have identified an in-
teresting link between ER stress, autophagy, and insulin resistance.
They have demonstrated that obesity induces insulin resistance by
ER stress-dependent down-regulation of the IR; and, ER stress-
stimulated IR degradation is mediated by the autophagy-
dependent process. They also demonstrated that the expression
levels of IR were negatively associated with CHOP in insulin
target tissues of db/db mice and mice fed a high-fat diet. In the
work presented here we provide a plausible series of mechanisms
associated with GLP-1 analog treatment that result in a beneficial
relationship between autophagy and ER stress in hepatic steatosis.
Arguably, GLP-1 in our work reduced ER stress and promoted
autophagy, which, in turn, lead to reduction in both fat load and
unfolded proteins. The results of our studies both in vitro and in vivo
reveal restoration of normal metabolism in hepatocytes and
consequently improve their chances for survival. Taken together,
we have demonstrated that GLP-1 agonists can rescue hepatocytes
from toxic fatty acids in vitro, or steatosis in vivo, by promoting
autophagy and mitigating ER-stress mediated apoptosis. Further
work to consider GLP-1 agonists for the treatment of human
NAFLD is warranted both to fully understand the pathogenesis of
disease and potentially to prevent disease progression.
Materials and Methods
Primary hepatocyte culture fatty acid loading and
staining
Primary human hepatocytes were obtained through the Liver
Tissue Cell Distribution System, (University of Pittsburgh, PA),
funded by NIH Contract # N01-DK-7-0004/HHSN267007
00004C. Cultures were maintained in BEBM
H medium (Lonza,
Allendale, NJ) with BEGM
H SingleQuots (Lonza). For all in vitro
experimental procedures hepaotcytes were grown and maintained
in the absence of insulin. Protein and RNA were subsequently
extracted. Long-chain fatty acids were purchased from Sigma
Aldrich (St. Louis, MO), palmitic acid (16:0), oleic acid (18:1 cis),
and elaidic acid (18:1 trans). Untreated cells at 48 h did not have
significantly different survivability rates when compared to cell
survival at plating upon arrival.
All three fatty acids were dissolved in isopropanol to obtain a
concentration of 100 mM. The required volume of the fatty acid
stock was added to the medium containing 1% bovine serum
albumin to obtain an 800 mM concentration of fatty acids in
experiments. This concentration of fatty acids was similar fasting
plasma concentrations of fatty acids under human nonalcoholic
steatohepatitis conditions [43,44]. The concentration of the
vehicle, isopropanol, was less than 1% in final culture media.
Cells were treated with each fatty acid independently and in
combination of all the three at 200 mM each. Cells that were
treated with the mix of all three fatty acid were unable to survive
after 24 hours (data not shown). Cells were treated with fatty acid
containing media for 24 h after which the media were changed
and supplemented with 10 nM exendin-4 (Sigma) while main-
taining fatty acid stress. Hepatocytes that were not provided
exendin-4 were cultured for an additional 24 h. After treatment
with exendin-4 for 24 h cells were harvested for staining with Oil
Red O.
ORO stain (Sigma) was used to stain the cells after fixing as per
following protocol. The cells were then visualized under the
Olympus IX-51 (Center Valley, PA) inverted microscope at
various magnification. To quantify the change in Oil Red O
staining between treatments, protocol published by Dragunow et
al. [45] was employed. The extracts were observed under the
Synergy 2 spectrophotometer at 510 nm wavelength using Gen5
software (Bio-Tek, Winooski, VT).
Cell survival assay
Cultured hepatocyte-viability following treatments with fatty
acids and/or exendin-4, was evaluated using the Cell Proliferation
Kit II (Roche, Indianapolis, IN) as per the manufacturer’s
protocol. Briefly, cultured cells were rinsed and treated with
XTT for 12 h before reading absorbance of the modified dye at
680 and 492 nm. Assays were performed in triplicates. DAPI
staining was resorted to visualize DNA condensation as a response
to apoptosis.
Preparation of cell lysates
Cells were harvested by centrifugation, washed with PBS, and
resuspended in 0.1mL of lysis buffer containing 1% Triton X-100,
10mM Tris, pH 7.6, 50mM NaCl, 0.1% BSA, 1mM phenyl-
methyl sulfonyl fluoride (PMSF), 1% aprotinin, 5mM EDTA,
50mM NaF, 0.1% 2-mercaptoethanol, 5mM phenylarsine oxide,
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by centrifugation at 14,0006g at 4uC for 20min.
RNA analysis
Total RNA was extracted from liver tissue and hepatocyte cell
culture using the Qiagen RNeasy Mini Kit (Qiagen, Valencia,
CA). Equal amounts of total RNA was used to synthesize the first
DNA strand by iScript cDNA Synthesis Kit (Bio-Rad, Hercules,
CA). Real-time quantitative PCR (RT-qPCR) was performed with
the Eppendorf Realplex4 (Hauppauge, NY) thermocycler, using
SYBR green (BioRad, Hercules, CA). Primer sequences used are
listed in Table 1. All samples were run in triplicate and PCR
products were normalized to 18s rRNA expression levels.
Additionally, actin expression levels were also determined to
confirm any changes in 18s levels between treatments (Fig. S2).
Immunoblotting and immunohistochemistry
Equal amounts of protein from cell and tissue lysates were
resolved on SDS-PAGE [46] and transblotted on PVDF
membrane (BioRad, Hercules, CA). A standard immunodetection
protocol was employed using primary antibodies for GRP78
(Santa Cruz, location), CHOP, cleaved caspase 3, beclin, LC3B,
LAMP2A (Cell Signaling) and ß-actin (Sigma) [47], and
bafilomycin (Sigma). Samples were detected using HyGlo
Chemiluminescent HRP Antibody Detection Reagent (Denville
Scientific, Metuchen, NJ) on an automated Biospectrum Imaging
System (UVP, Cambridge, UK).
Assessment of autophagic flux
To assess the autophagic flux, cells were treated with palmitic
acid as above, followed by 2.5 nM bafilomycin A1 (Sigma)
treatment for 4 hrs. Subsequently the cells were treated with 10
nM exendin-4 in presence of palmitic acid and bafilomycin for an
additional 6 hrs. After the end point cells were harvested for
immunoblotting. Respective controls were maintained in which
bafilomycin, palmitic acid and/or exnedin-4 were not added.
Blotted membranes were subject to immunodetection with LC3
antibody followed by densitometry of the developed blots on
ChemiDoc XRS+ using ImageLab software (BioRad, Hercules,
CA, USA). To assess the autophagic flux between control, palmitic
acid and/or exendin-4, ratio of the densitometry values of LC3-II
bands of bafilomycin treated samples to respective bafilomycin-
free samples was taken. The results thus obtained were plotted on
a histogram to determine the change in the flux.
Quantification of autophagic vacuoles by transmission
electron microscopy (TEM)
Immediately after cell culture treatments were complete media
was aspirated and 2.5% glutaraldehyde fixative [10 ml 25%
glutaraldehyde (EMS, Fort Washington, PA), 50 ml 0.2 M
cacodylate buffer, pH 7.4, 40 ml distilled water] was added to
wells. Cells were left in fixative for a minimum of 2 hours at 4uC.
Cells were then washed twice with 0.1 M cacodylate buffer at
room temperature with agitation for 5 min. Following washes, 1%
osmium fixative [2 parts 0.2 M cacodylate buffer, 1 part 6%
potassium ferrocyanide (Sigma), 1 part 4% osmium tetroxide
(EMS)] was added to cells and cells were left at room temperature
for 1 h. Cells were then washed twice with 0.1 M cacodylate
buffer, pH 7.4, at room temperature with agitation for 5 min.
Fixed cells were dehydrated with a series of ethanol treatments
(25%, 2 min; 50%, 2 min; 70%, 2 min; 95%, 2 min; 100%,
362 min). Following dehydration, cells were infiltrated with Epson
resin (100% EtOH and Epson resin, 1:1 for 1 hours followed by
pure Epson resin, overnight).
After sections were cut and loaded on grid, they were observed
under a Hitachi H-7500 Transmission Electron Microscope fitted
with a Gatan BioScan 1K CCD camera, under various magni-
fications. Autophagic vacuoles (including autophagosomes and
autophagolysosomes) were counted following the defined protocols
[48,49]. Briefly, the grids were loaded on the microscope and
scanned systematically starting from the left edge at the bottom of
the grid with surveillance of the specimen to score for AVs and
ALs ascertaining that systematic sampling is achieved. Separate
records of autophagosomes and autophagolysosomes were made
to assess the total autophagic response.
Mouse feeding studies
Male C57BL/J6 4-5 wk old mice were obtained from Jackson
Laboratories (Bar Harbor, ME). All animal work was performed in
accordance to relevant national and international guidelines. The
work was approved by Emory University’s Institutional Animal
Care and Use Committee protocol # 065-2009. Animals were
housed in laboratory cages at 23uC under a 12-hour light/dark
cycle. Mice were fed either standard chow or the American
Lifestyle-Induced Obesity Syndrome (ALIOS) diet as described by
Tetri et al. [50]. The ALIOS diet provides 45% of calories from fat,
with 30% of the fat in the form of partially hydrogenated vegetable
oil [28% saturated, 57% monounsaturated fatty acids (MUFA),
13% polyunsaturated fatty acids (PUFA); trans-fat custom diet
TD06303, Harlan Teklad)]. ALIOS-fed mice were also given high
fructose corn syrup equivalents in their drinking water at 42 g/L
(55% fructose, 45% glucose by weight) hereafter termed ALIOS-
fed. Control mice were fed standard rodent chow. Food and water
consumption were measured by weighing new and remaining food
and volumes of water three times weekly. After 8 weeks on the
diet, mice were injected with saline or 200 mg/kg of body weight
Table 1. Primers used for real-time PCR.
Organism Gene Primer
Human GRP78 Forward GCCGTCCTATGTCGCCTTC
GRP78 Reverse TGGCGTCAAAGACCGTGTTC
CHOP Forward TGGAAGCCTGGTATGAGGAC
CHOP Reverse TGTGACCTCTGCTGGTTCTG
BECN1 Forward ACCTCAGCCGAAGACTGAAG
BECN1 Reverse AACAGCGTTTGTAGTTCTGACA
LC3B Forward AAGGCGCTTACAGCTCAATG
LC3B Reverse CTGGGAGGCATAGACCATGT
LAMP2 Forward TTGGTTAATGGCTCCGTTTTCA
LAMP2 Reverse ACAAGGAAGTTGTCGTCATCTG
XBP1 Forward TTACGAGAGAAAACTCATGGCC
XBP1 Reverse GGGTCCAAGTTGTCCAGAATGC
Mouse GRP78 Forward CTGAGGCGTATTTGGGAAAGAA
GRP78 Reverse TGACATTCAGTCCAGCAATAGTG
CHOP Forward CTGGAAGCCTGGTATGAGGAT
CHOP Reverse CAGGGTCAAGAGTAGTGAAGGT
BECN1 Forward ATGGAGGGGTCTAAGGCGTC
BECN1 Reverse TCCTCTCCTGAGTTAGCCTCT
LC3B Forward TTATAGAGCGATACAAGGGGGAG
LC3B Reverse CGCCGTCTGATTATCTTGATGAG
doi:10.1371/journal.pone.0025269.t001
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feeding analysis and water consumption was not significantly
different among different mouse cohorts including those ALIOS-
fed mice compared to mice fed standard chow and water (data not
shown).
Statistical Analysis
All the experiments were conducted at least three times in
triplicate. The data are presented as means 6 standard error
(SEM). Statistical analysis was performed using JMP v.8.01 (SAS
Institute, Cary N.C.). Means were compared using the Student’s t-
test. The Tukey-Kramer test was also used to determine if any
group differed significantly from each other.
Supporting Information
Figure S1 (A) ER stress establishment. PERK phosphor-
ylation was confirmed by immunoblot using phospho-PERK
antibody (Santa Cruz # sc-32577). PERK phosphorylation was
greater in fat loaded cells when compared to controls. Exendin-4
treatment of fatty acid loaded cells did not show significant
difference from fatty acid loaded cells in the absence of exendin-4
treatment. (B). PCR for assessing XBP splicing. XBP
splicing was detected following the protocol of Cawley et al [1].
(C) XBP splicing in fatty acid loaded cells confirmed that ER
stress was increased in hepatocytes; however, was reduced after
exendin-4 treatment. We also observed splicing in exendin-4
treated samples in cells not loaded with fatty acids, though other
markers of ER stress were not observed (c.f. Fig. 3). 1. Cawley K,
Deegan S, Samali A, Gupta S (2011) Assays for detecting the
unfolded protein response. Methods Enzymol 490: 31–51.
(TIF)
Figure S2 Confirmation of lack of changes in 18s rRNA
between treatments. RT-qPCR of all samples for ß-Actin
revealed absence of difference between expression of housekeeping
gene 18s rRNA regardless of treatments.
(TIF)
Figure S3 Exendin-4 induces fatty acid ß-oxidation.
Histogram showing increased levels of beta hydroxybutyrate in
culture media, which was significantly increased (#:p ,0.001,
*: p,0.05) in media obtained from both palmitic and elaidic acid-
loaded hepatocytes treated with exendin-4 as compared to oleic
acid containing hepatocytes. The results are from three indepen-
dent experiments, *p,0.05, Student’s t-test.
(TIF)
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